Transcatheter Aortic Valve Implantation (TAVI) Market 2019 Emerging Technologies and Forecast 2025 by Top Brands Abbott Laboratories, Boston Scientific Corporation
The transcatheter aortic valve implantation (TAVI) market revenue was valued at $2,761 million in 2017 and is expected to reach $8,158 million by 2025, growing at a CAGR of 15.8% from 2018 to 2025. The volume market was valued at 107,011 units in 2017 and is expected to reach 557,778 units by 2025, growing at a CAGR of 14.8% from 2018 to 2025.
View full press release